ZimVie Reports Third Quarter 2023 Financial Results and Provides Update to Annual Guidance
November 01, 2023 16:05 ET
|
ZimVie Inc.
Third Party Net Sales of $202.9 millionNet Loss of ($5.1) million; Net Loss Margin of (2.5%); Adjusted Net Income[1] of $2.2 millionDiluted EPS of ($0.19); Adjusted Diluted EPS[1] of $0.08Adjusted...
ZimVie Announces First U.S. Surgery with the 4.5mm Mobi-C® Cervical Disc
October 31, 2023 08:00 ET
|
ZimVie Inc.
WESTMINSTER, Colo., Oct. 31, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced that the first patient in the United...
ZimVie Announces Over 2,000 Children Have Received The Tether™ VBT
October 24, 2023 08:00 ET
|
ZimVie Inc.
WESTMINSTER, Colo., Oct. 24, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced that over 2,000 children worldwide...
ZimVie Announces the Launch of Azure™ Multi-Platform Product Solutions
October 17, 2023 08:30 ET
|
ZimVie Inc.
WESTMINSTER, Colo., Oct. 17, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced the recent launch of Azure™...
ZimVie to Report Third Quarter 2023 Financial Results on November 1, 2023
October 11, 2023 16:05 ET
|
ZimVie Inc.
WESTMINSTER, Colo., Oct. 11, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, announced it will report financial results for the...
ZimVie Announces the Recent Launch of Biotivity™ A/C Plus Membrane
October 10, 2023 08:30 ET
|
ZimVie Inc.
WESTMINSTER, Colo., Oct. 10, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced the recent launch of the Biotivity™...
ZimVie Announces FDA Approval to Launch Mobi-C® Hybrid Study
September 26, 2023 08:00 ET
|
ZimVie Inc.
WESTMINSTER, Colo., Sept. 26, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced that on September 7, 2023, the U.S....
ZimVie Expands Development Cooperation Agreement with Brainlab AG to Include Co-Marketing
August 17, 2023 08:00 ET
|
ZimVie Inc.
ZimVie and Brainlab will cooperate on achieving compatibility between ZimVie’s Vital™ and Virage® fixation systems with the Brainlab spine and trauma technologies for global co-marketing purposes ...
ZimVie Announces FDA Approval for New Mobi-C® Implant
August 10, 2023 08:00 ET
|
ZimVie Inc.
WESTMINSTER, Colo., Aug. 10, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced that on August 1st, 2023, the U.S. Food...
ZimVie Reports Second Quarter 2023 Financial Results and Provides Update to Annual Guidance
August 02, 2023 16:05 ET
|
ZimVie Inc.
Third Party Net Sales of $224.9 millionNet Loss of ($23.4) million; Net Loss Margin of (10.4%); Adjusted Net Income[1] of $4.3 millionDiluted EPS of ($0.89); Adjusted Diluted EPS[1] of $0.17Adjusted...